Centre Oscar Lambret
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 · Thierry Conroy, Françoise Desseigne, et al. · New England Journal of Medicine
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
2012 · Rafael Rosell, Enric Carcereny, et al. · The Lancet Oncology
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 · Jacques Bernier, C. Domenge, et al. · New England Journal of Medicine